Recombinant DNA Technology Global Market Report 2025 Market Forecast Report Outlines Size, Share, And Growth Opportunities Through 2029

 What Growth Rate And Market Size Expansion Are Predicted For The Recombinant DNA Technology Global Market Report 2025 Market Across The Forecast Period?

 The recombinant dna technology market size has grown strongly in recent years. It will grow from $858.94 billion in 2024 to $913.42 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to healthcare demands, biopharmaceutical industry growth, rising investments in R&D, emergence of personalized medicine.



 
 The recombinant dna technology market size is expected to see strong growth in the next few years. It will grow to $1299.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to rising chronic diseases, emerging biotech startups, increasing funding in biotech, globalization of biotech markets, consumer acceptance and education. Major trends in the forecast period include scientific advancements, gene editing advancements, cell and gene therapies, development of RNA therapeutics, therapeutic applications in rare diseases, AI and data integration.
 
 Claim Your Free Report Sample Today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=8233&type=smp
 
 Which Underlying Drivers Are Influencing The Rapid Growth Of The Recombinant DNA Technology Global Market Report 2025 Market?
 The increasing number of chronic diseases is expected to propel the growth of the recombinant DNA technology market. Chronic diseases, which are defined as ailments that last for a year or longer, necessitate continuing medical care, restrict everyday activities, or both. Recombinant DNA technology has improved healthcare by creating biopharmaceuticals proteins used in pharmaceuticals and by replacing defective genes with healthy ones through gene therapy, aiming to cure illness. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increase in chronic diseases is driving the growth of the recombinant DNA technology market.
 
 What Segmentation Areas Represent Major Opportunities For Expansion In The Recombinant DNA Technology Global Market Report 2025 Market?
 The recombinant dna technologymarket covered in this report is segmented — 
 
 1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell And Gene Therapy, Gene Editing 
 2) By Component Type: Expression System, Cloning Vector
 3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types
 4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types
 
 Subsegments:
 1) By Recombinant Protein Drugs: Hormones, Growth Factors
 2) By Vaccines: Recombinant Viral Vaccines, Recombinant Bacterial Vaccines, Subunit Vaccines
 3) By Genetically Modified Crops: Herbicide-Tolerant Crops, Insect-Resistant Crops, Nutritionally Enhanced Crop 
 4) By Expression Systems: Bacterial Expression Systems, Yeast Expression Systems, Mammalian Expression Systems
 5) By Cell And Gene Therapy: Cell-Based Therapies, Gene Replacement Therapies, CAR T-Cell Therapies
 6) By Gene Editing: CRISPR Or Cas9 Technologies, TALENs (Transcription Activator-Like Effector Nucleases), ZFNs (Zinc Finger Nucleases)
 
 Which Strategic Trends Are Likely To Impact Competitive Positioning In The Recombinant DNA Technology Global Market Report 2025 Market?
 Technological advancement is a key trend in the recombinant DNA technology market. Major companies operating in the recombinant DNA technology market are focused on innovative technologies to sustain their position in the market. For instance, in August 2022, Bluebird bio, Inc., a US-based biotechnology company launched U.S. Food and Drug Administration (FDA) approved ZYNTEGLO. It is a one-time gene therapy that treats beta-thalassemia by targeting its genetic cause, offering patients the chance to become independent of regular red blood cell transfusions. It uses an ex-vivo lentiviral vector to modify patient cells and is the first FDA-approved gene therapy for this condition in the U.S. This breakthrough reduces the lifelong burden of managing beta-thalassemia. 
 
 Which Leading Players Have A Strong Presence In The Recombinant DNA Technology Global Market Report 2025 Market?
 Major companies operating in the recombinant DNA technology market are Profacgen BioTech Corp., Amgen Inc., Novartis International AG, GenScript Biotech Corporation, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Co. Inc., Biogen Inc., GlaxoSmithKline PLC, New England Biolabs Inc., Bayer CropScience, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Gilead Sciences Inc., Moderna Inc., Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics AG, Editas Medicine Inc., bluebird bio Inc., Illumina Inc., Qiagen N.V., Lonza Group AG, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Becton Dickinson and Company, Sartorius AG, Abcam PLC, Horizon Discovery Group PLC, Integrated DNA Technologies Inc., Twist Bioscience Corporation, Synthego Corporation, Codex DNA Inc., InvivoGen, Eurofins Scientific SE, Sarepta Therapeutics Inc., Sangamo Therapeutics Inc. 
 
 Get Your In-Depth Recombinant DNA Technology Global Market Report 2025 Market Report Now:
 https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report
 
 Which Parts Of The World Are Emerging As High-Potential Markets For The Recombinant DNA Technology Global Market Report 2025 Market?
 North America was the largest region in the recombinant DNA technology market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant DNA technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Global Next-Generation Advanced Batteries Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    How Is the Next-Generation Advanced Batteries Market Expected to Expand in Terms of Size and Growth?  The next-generation advanced batteries market size has grown rapidly in recent years. It will grow from $14.21 billion in 2025 to $15.93 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to increasing adoption of electric vehicles, integration with renewable energy systems, the need for cost-effective alternatives to lithium-ion batteries, growing demand for energy storage solutions, government in...
Read more

Intense Pulsed Light (IPL) Facial Rejuvenation Device Industry Projected to Experience Accelerated Growth by 2029

Image
 Get 30% Off All Market Studies With Code ONLINE30 — Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends    What Is the Intense Pulsed Light (IPL) Facial Rejuvenation Device Market Growth Potential Across Different Regions?  The intense pulsed light (IPL) facial rejuvenation device market size has grown rapidly in recent years. It will grow from $1.05 billion in 2024 to $1.18 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to growing influence of social media beauty standards, increasing preference for youthful appearance, rising penetration of aesthetic clinics, rise in technological adoption in dermatology practices, increasing awareness of early anti-aging treatments.    The intense pulsed light (IPL) facial rejuvenation device market size is expected to see rapid growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate ...
Read more

Global Aggregate Stockpile Drones Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    What Is the Forecasted Market Size of the Aggregate Stockpile Drones Market by 2030?  The aggregate stockpile drones market size has grown rapidly in recent years. It will grow from $1.04 billion in 2025 to $1.20 billion in 2026 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to growing need for accurate stockpile measurement, increasing adoption of drones in mining operations, rising focus on worker safety during surveying, expansion of quarry and aggregates production activities, growing shift from manual to ...
Read more